While our study revealed the role of PSMD1 in HCC proliferation and its function in immunotherapy, the posttranslational modifications of PSMD1 and their impact on the inhibition of RTKN ubiquitination-mediated degradation remain unclear. The gene discussed is RTKN; the disease is hepatocellular carcinoma.